866-997-4948(US-Canada Toll Free)

OTC Pain Management - US - June 2017

Published By :

Mintel

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : N/A

A majority of consumers turn to some form of OTC (over-the-counter) pain management product to treat pain, with internal analgesics remaining the dominate choice for pain relief, though external analgesics continue to experience faster growth. Looking forward, consumers’ need for pain treatments is not expected to change, and a preference for familiar brands will remain; however, interest is growing for naturally-positioned remedies.

Table of Content

OVERVIEW
What you need to know
Definition

EXECUTIVE SUMMARY
The issues
Consumers who stock up are less satisfied with their pain reliever
Figure 1: Keep OTC on hand and satisfaction with current pain reliever, by pain self-assessment, April 2016
Dependency concerns and war on opioids could impact analgesic sales
Figure 2: Dependency concern, April 2017
The benefits of feminine pain relievers less apparent to key consumer group
Figure 3: Feminine pain relievers work the same as any oral pain reliever, by age, April 2017
The opportunities
Those with unbearable, constant, long-term pain still seeking relief
Figure 4: Willingness to try new pain relievers, try anything, and rely on daily pain reliever, by pain self-assessments, April 2017
Newer pain relieving formats have limited use, yet significant potential
Figure 5: regular use and interest in using external patch/wrap and TENS device, April 2017
Free-from claims can boost natural perceptions
Figure 6: Share of pain reliever product launches, by claim, 2012-16
What it means

THE MARKET – WHAT YOU NEED TO KNOW
Sales of OTC remedies remain steady, a result of pervasive pain
External analgesics growing, while internal accounts for vital quantity
OTC TENS market the new breakout in pain management
Age dynamics and the war on opioids impact product sales

MARKET SIZE AND FORECAST
Pain and sales of OTC remedies are constant
Figure 7: Total US sales and fan chart forecast of OTC analgesics and pain management devices, at current prices, 2012-22
Figure 8: Total US retail sales and forecast of OTC analgesics and pain management devices, at current prices, 2012-22

MARKET BREAKDOWN
Sales of pain relieving products continue in stride
Figure 9: Total US retail sales and forecast of OTC analgesics and pain management devices, by segment, at current prices, 2012-22
Figure 10: Total US retail sales and forecast of OTC analgesics and pain management devices, by segment, at current prices, 2015 and 2017

MARKET PERSPECTIVE
OTC TENS market expected to grow; more devices hit the market
Figure 11: Total US retail sales of OTC TENS devices, at current prices, 2014-16
Figure 12: MULO sales of electrotherapy devices, by leading companies and brands, rolling 52 weeks 2016 and 2017

MARKET FACTORS
Age impacts choice in pain management
Figure 13: US population aged 18 or older, by age, 2011-21
The war on opioids: the push to reduce abuse

KEY PLAYERS – WHAT YOU NEED TO KNOW
J&J is the leader in pain management sales
External analgesics segment growth outpaces internal remedies
Minimal innovation and absence of a defined need stalls sales
Free-from, improved package functionality, and product blurring

COMPANY AND BRAND SALES OF OTC PAIN RELIEVERS
Trust is reclaimed; J&J is back on top while Bayer and Pfizer drop
Figure 14: MULO sales of OTC pain medication and devices, by leading companies, rolling 52 weeks 2016 and 2017

WHAT’S WORKING?
External analgesics’ sales boom due to a flood of Lidocaine
Figure 15: MULO sales of external analgesics, by leading brands, rolling 52 weeks 2016 and 2017
J&J keeps gaining market share
Figure 16: MULO sales of internal analgesics, by leading companies and brands, rolling 52 weeks 2016 and 2017
Retail presence a must for new introductions to gain widespread use

WHAT’S STRUGGLING?
Minimal innovation stalls muscle support device and ice/heat pack sales
Figure 17: Total MULO sales of muscle/body support devices and ice/heat packs, rolling 52 weeks 2016 and 2017
“Pink” pain relievers are not attaining acceptance
Figure 18: MULO sales of feminine pain relievers, by leading brands, rolling 52 weeks 2016 and 2017

WHAT’S NEXT?
Fragrance-free and free-from ingredient claims on the rise
Figure 19: Share of pain reliever product launches, by claim, 2012-16
Reducing the pain of opening the pill bottle
New product launch blurs product lines

THE CONSUMER – WHAT YOU NEED TO KNOW
Most adults experience pain and in multiple places of the body
Internal analgesics are pervasive, external have more limited users
Retail stores are the go-to for pain relievers
For most people pain is occasional and tolerable
People focus on overall wellbeing and new products for relief
Many consumers keep a pain reliever on hand

LOCATION OF PAIN
Most adults experience pain; headache or back pain are leading types
Figure 20: Location of pain repertoire, April 2017
Figure 21: Location of pain, April 2017
Number and types of pain experienced vary some by age
Figure 22: Location of pain repertoire, by age, April 2017
Figure 23: Location of pain, by age, April 2017
Headaches and migraines impact women most
Figure 24: Headache and migraine pain, by gender, April 2017
White and Hispanic adults experience more pains
Figure 25: Location of pain repertoire, by race and Hispanic origin, April 2017

PAIN RELIEVER USAGE
Internal OTC pain relievers are the common go-to for relief
Figure 26: Pain reliever use, April 2017
External pain relievers have more limited regular users
Figure 27: Profile of regular external OTC medicated rub/ointment pain reliever users, April 2017
Figure 28: Profile of regular external OTC medicated patch/wrap pain reliever users, April 2017
Newer pain relieving formats have limited use, yet significant potential
Figure 29: Regular use and interest in using external patch/wrap and TENS device, April 2017
Regular pain reliever use increases with additional pain experienced
Figure 30: Regularly use for pain relief, by repertoire of source of pain, April 2017

PURCHASE LOCATION
Retail stores are the go-to for pain relievers
Figure 31: Pain reliever purchase location, April 2017
Young adults are shopping drug stores most for relief
Figure 32: Pain reliever purchase location, by age, April 2017
TENS devices have an online presence
Figure 33: TENS device purchase location, April 2017

PAIN SELF-ASSESSMENT
For the most part pain occurs on occasion and is tolerable
Figure 34: Pain self-assessment, April 2017
Most people describe pain as somewhere in the middle
Figure 35: Unbearable or tolerable pain self-assessment, by types of pain, April 2017
Figure 36: Constant or occasional pain self-assessment, by types of pain, April 2017
The more types the less tolerable the pain
Figure 37: Unbearable or tolerable pain self-assessment, by repertoire of source of pain, April 2017
Unbearable pain is more constant; tolerable pain is occasional
Figure 38: Unbearable or tolerable pain self-assessment, by occasional or constant pain self-assessment, April 2017

GENERAL ATTITUDES AND BEHAVIORS
People will seek out relief for the benefit of their health
Figure 39: General attitudes and behaviors, April 2017
Natural and non-medicinal options could ease dependency concerns
Figure 40: General attitudes and behaviors, by gender and age, April 2017
Those with unbearable, constant, long-term pain still seeking relief
Figure 41: General attitudes and behaviors, by pain self-assessments, April 2017
The type of pain people experience dictates pain reliever use
Figure 42: Location of pain by general attitudes and behaviors, April 2017

ATTITUDES TOWARD OTC MEDICATIONS
Preparedness is the first defense in managing pain
Figure 43: Attitudes toward OTC medications, April 2017
Those with enduring pain keep something on hand, but are less satisfied
Figure 44: Pain self-assessment, by Attitudes toward OTC medications, April 2016
Older adults are habitual; young adults seek out value
Figure 45: Attitudes toward OTC medications, by gender and age, April 2017
Women using feminine pain relievers agree less with the need
Figure 46: Feminine pain relievers work the same as any oral pain reliever, by age, April 2017

APPENDIX – DATA SOURCES AND ABBREVIATIONS
Data sources
Sales data
Fan chart forecast
Consumer survey data
Abbreviations and terms
Abbreviations

APPENDIX – THE MARKET
Figure 47: Total US retail sales and forecast of OTC analgesics and pain management devices, at inflation-adjusted prices, 2012-22
Figure 48: Total US retail sales and forecast of OTC analgesics and pain management devices, by segment, at current prices, 2012-22
Figure 49: Total US retail sales of OTC analgesics and pain management devices, by channel, at current prices, 2012-17
Figure 50: MULO sales of electrotherapy devices, by leading companies and brands, rolling 52 weeks 2016 and 2017

APPENDIX – KEY PLAYERS
Figure 51: MULO sales of external analgesics, by leading companies and brands, rolling 52 weeks 2016 and 2017
Figure 52: MULO sales of muscle/body support devices, by leading companies and brands, rolling 52 weeks 2016 and 2017
Figure 53: MULO sales of ice/heat packs, by leading companies, rolling 52 weeks 2016 and 2017

APPENDIX – THE CONSUMER
Figure 54: Profile of regular heat/ice pack pain reliever users, April 2017
Figure 55: Profile of regular muscle/body support pain reliever users, April 2017

List of Table

NA

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *